Kolexia
Wagner Mathilde
Radio-diagnostic
Hôpital Pitie Salpetriere
Paris, France
133 Activités
1 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du foie Carcinome hépatocellulaire Carcinomes Cirrhose du foie Fibrose Adénocarcinome Métastase tumorale Tumeurs colorectales Maladies du foie

Industries

Bayer
5 collaboration(s)
Dernière en 2023
B3TSI
2 collaboration(s)
Dernière en 2022
Bracco Imaging
2 collaboration(s)
Dernière en 2023
Mayoly Spindler
1 collaboration(s)
Dernière en 2021

Dernières activités

Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
Radiology   28 février 2024
Deep learning for automatic bowel-obstruction identification on abdominal CT.
European radiology   22 février 2024
No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCC.
Liver international : official journal of the International Association for the Study of the Liver   30 janvier 2024
Appendiceal adenocarcinoma, diagnosed after acute perforated appendicitis: Potential contribution of HIPEC.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology   19 janvier 2024
Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC: A promising approach for improved survival.
Clinics and research in hepatology and gastroenterology   06 janvier 2024
Splenic vein tumor thrombosis is a major prognostic factor in distal pancreatic adenocarcinoma.
Surgery   08 décembre 2023
Portal-hypertension features are associated with ascites occurrence and survival in patients with hepatocellular carcinoma treated by external radiotherapy.
United European gastroenterology journal   29 novembre 2023
Impact of radiological response and pattern of progression in patients with hepatocellular carcinoma treated by atezolizumab- bevacizumab.
Hepatology (Baltimore, Md.)   23 octobre 2023
Liver investigation: Testing marker utility in steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol.
Contemporary clinical trials   04 octobre 2023
Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC.
Clinics and research in hepatology and gastroenterology   02 septembre 2023